Showing results (81-90 of 324) with videos related to
Sort By:
Pageof 33
Cancer Investigation|December 21, 2010
Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanomaJudy Ahrar, Sanjay Gupta, Joe Ensor, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2014
Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activationManisha Singh, Hiep Khong, Zhimin Dai, et al.Cancer Research|August 24, 2012
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokinesWeiyi Peng, Chengwen Liu, Chunyu Xu, et al.Head & Neck|September 18, 2008
Biochemotherapy in patients with advanced head and neck mucosal melanomaHolly L Bartell, Agop Y Bedikian, Nicholas E Papadopoulos, et al.International Journal of Radiation Oncology, Biology, Physics|September 27, 2005
Combined-modality therapy for patients with regional nodal metastases from melanomaMatthew T Ballo, Merrick I Ross, Janice N Cormier, et al.Molecular Cancer Therapeutics|July 27, 2016
Hypoxia-Driven Mechanism of Vemurafenib Resistance in MelanomaYong Qin, Jason Roszik, Chandrani Chattopadhyay, et al.American Journal of Clinical Oncology|November 26, 2009
Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factorsSanjay Gupta, Agop Y Bedikian, Judy Ahrar, et al.Cancers|February 27, 2026
Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-AnalysisIslam Eljilany, Eissa Jafari, Abdullah Alhumaid, et al.Immunity|November 3, 2009
T helper 17 cells promote cytotoxic T cell activation in tumor immunityNatalia Martin-Orozco, Pawel Muranski, Yeonseok Chung, et al.BMC Cancer|April 18, 2015
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistanceJennifer Wheler, Roman Yelensky, Gerald Falchook, et al.Pageof 33